Most Recent Posts
Creating the Next Moderna: What VC Offers the World and 3 Public Policy Lessons
11/30/2020
Pfizer is a well-known U.S. drug company, but few Americans had heard of Moderna before the company made headlines for pursuing a COVID vaccine.
Why it matters: The company is a fascinating case study in American innovation and provides a roadmap for policymakers to support U.S. leadership in scientific and technological advancement.
CFIUS & VC: 3 Takeaways from the Final Rules and What Investors Must Know
01/27/2020
The Treasury Department released the long-awaited final rules implementing the Foreign Investment Risk Review Modernization Act (FIRRMA).
A deeper look: Through FIRRMA, Congress gave CFIUS significant new powers to police investments into certain U.S. companies and has made CFIUS highly relevant in the startup ecosystem. NVCA details 3 key takeaways for VCs.
Foreign investment scrutiny: 5 questions every venture investor should know the answer to
10/15/2018
READ MORE